DALT: Difference between revisions
Content deleted Content added
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
{{notability|date=October 2014}} |
|||
{{Drugbox |
{{Drugbox |
||
| Watchedfields = changed |
| Watchedfields = changed |
||
| Line 40: | Line 39: | ||
}} |
}} |
||
'''''N'',''N''-Diallyltryptamine''' ('''DALT''') is a [[tryptamine]] [[derivative (chemistry)|derivative]]. It has been used as an intermediate in the preparation of [[radiolabeled]] [[diethyltryptamine]].<ref>{{cite journal |author1=Brandt, SD |author2=Tirunarayanapuram, SS |author3=Freeman, S |author4=Dempster, N |author5=Barker, SA |author6=Daley, PF |author7=Cozzi, NV |author8=Martins, CPB | title = Microwave-accelerated synthesis of psychoactive deuterated N,N-dialkylated-[α,α,β,β-d4]-tryptamines | journal = J. Labelled Compd. Radiopharm | date = 2008 | volume = 51 | issue = 14 | pages = 423–429 | doi = 10.1002/jlcr.1557}}</ref> |
'''''N'',''N''-Diallyltryptamine''' ('''DALT''') is a [[tryptamine]] [[derivative (chemistry)|derivative]] which has been identified as a new psychoactive substance.<ref>Michely JA, Helfer AG, Brandt SD, Meyer MR, Maurer HH. Metabolism of the new psychoactive substances N,N-diallyltryptamine (DALT) and 5-methoxy-DALT and their detectability in urine by GC-MS, LC-MSn, and LC-HR-MS-MS. ''Anal Bioanal Chem''. 2015 Oct;407(25):7831-42. {{pmid|26297461}} {{doi|10.1007/s00216-015-8955-0}}</ref><ref>Michely JA, Brandt SD, Meyer MR, Maurer HH. Biotransformation and detectability of the new psychoactive substances N,N-diallyltryptamine (DALT) derivatives 5-fluoro-DALT, 7-methyl-DALT, and 5,6-methylenedioxy-DALT in urine using GC-MS, LC-MSn, and LC-HR-MS/MS. ''Anal Bioanal Chem''. 2017 Feb;409(6):1681-1695. {{pmid|27933361}} {{doi|10.1007/s00216-016-0117-5}}</ref> It has been used as an intermediate in the preparation of [[radiolabeled]] [[diethyltryptamine]].<ref>{{cite journal |author1=Brandt, SD |author2=Tirunarayanapuram, SS |author3=Freeman, S |author4=Dempster, N |author5=Barker, SA |author6=Daley, PF |author7=Cozzi, NV |author8=Martins, CPB | title = Microwave-accelerated synthesis of psychoactive deuterated N,N-dialkylated-[α,α,β,β-d4]-tryptamines | journal = J. Labelled Compd. Radiopharm | date = 2008 | volume = 51 | issue = 14 | pages = 423–429 | doi = 10.1002/jlcr.1557}}</ref> |
||
== See also == |
== See also == |
||
Revision as of 10:03, 8 January 2020
 | |
| Clinical data | |
|---|---|
| Routes of administration | Oral, insufflated, rectal, smoked, IM, IV[citation needed] |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C16H20N2 |
| Molar mass | 240.34 g/mol g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
N,N-Diallyltryptamine (DALT) is a tryptamine derivative which has been identified as a new psychoactive substance.[1][2] It has been used as an intermediate in the preparation of radiolabeled diethyltryptamine.[3]
See also
References
- ^ Michely JA, Helfer AG, Brandt SD, Meyer MR, Maurer HH. Metabolism of the new psychoactive substances N,N-diallyltryptamine (DALT) and 5-methoxy-DALT and their detectability in urine by GC-MS, LC-MSn, and LC-HR-MS-MS. Anal Bioanal Chem. 2015 Oct;407(25):7831-42. PMID 26297461 doi:10.1007/s00216-015-8955-0
- ^ Michely JA, Brandt SD, Meyer MR, Maurer HH. Biotransformation and detectability of the new psychoactive substances N,N-diallyltryptamine (DALT) derivatives 5-fluoro-DALT, 7-methyl-DALT, and 5,6-methylenedioxy-DALT in urine using GC-MS, LC-MSn, and LC-HR-MS/MS. Anal Bioanal Chem. 2017 Feb;409(6):1681-1695. PMID 27933361 doi:10.1007/s00216-016-0117-5
- ^ Brandt, SD; Tirunarayanapuram, SS; Freeman, S; Dempster, N; Barker, SA; Daley, PF; Cozzi, NV; Martins, CPB (2008). "Microwave-accelerated synthesis of psychoactive deuterated N,N-dialkylated-[α,α,β,β-d4]-tryptamines". J. Labelled Compd. Radiopharm. 51 (14): 423–429. doi:10.1002/jlcr.1557.